Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
First-line Lenvima plus Keytruda yields better overall survival for patients with metastatic kidney cancer.
Nearly four years after vaccination, patients’ immune cells were still active against their cancer.
Focusing on the largest health care system in the Northeast, the study documents the pandemic’s impact on cancer screening and diagnosis.
Christine (“Chris”) Colpitt was scheduled for a stem cell transplant from her fully matched brother but he was at risk for COVID-19.
Study offers assurance that the benefits of the combination can be achieved without diminishing patients’ quality of life.
Keytruda can treat women whose endometrial cancer cells have certain characteristics.
However, the gap between white and Black patients still remains.
The drug targets cancer’s survival proteins, making them more vulnerable to treatments that cause cancer cells to self-destruct.
Yescarta led to complete remission in people with advanced non-Hodgkin lymphoma.
Husband and wife Ken Deutsch and Amy Green have each had to grapple with cancer, as well as multiple setbacks and even recurrences.
Antibody-drug conjugates are targeted agents that package cancer drugs for special delivery to tumor cells.
Julie Mizraji, who is living with metastatic breast cancer, ran her half-marathon birthday race with a little help from her friends.
The study represents the most comprehensive scientific survey to date about the interrelationship between COVID-19 and cancer.
While different screenings can be done at home, they are designed to inform people when they should see their doctor.
Adding Tecentriq to a three-drug chemotherapy regimen increases odds of remission of early-stage triple-negative breast cancer.
Lumpectomy is a surgery treatment for breast cancer, and is extremely safe and usually takes no more than an hour.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.